STOCK TITAN

Nexgel Inc Wt Exp 120126 Stock Price, News & Analysis

NXGLW Nasdaq

Welcome to our dedicated page for Nexgel Wt Exp 120126 news (Ticker: NXGLW), a resource for investors and traders seeking the latest updates and insights on Nexgel Wt Exp 120126 stock.

NexGel Inc (NXGLW) develops advanced hydrogel solutions for medical and cosmetic applications through proprietary electron beam cross-linking technology. This dedicated news hub provides investors and industry professionals with essential updates on the company’s innovations in wound care systems, transdermal delivery platforms, and material science breakthroughs.

Access timely announcements including regulatory milestones, strategic partnerships, product developments, and financial performance. Our curated collection ensures efficient tracking of NXGLW’s progress across key sectors: FDA-cleared medical devices, OTC hydrogel products, and custom manufacturing solutions for healthcare providers.

Discover press releases covering technical achievements, manufacturing expansions, and clinical application studies. All content is verified for accuracy and relevance to support informed analysis of NexGel’s market position in the competitive hydrogel industry.

Bookmark this page for centralized access to NXGLW’s material developments, presented with clarity for both technical experts and general investors. Regularly updated to reflect the company activities shaping next-generation hydrogel applications.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Rhea-AI Summary

NEXGEL reported a 32% year-over-year revenue increase, reaching $2.05 million for 2022, driven by 34.7% growth in contract manufacturing and a 67.0% rise in branded consumer products. By year-end, the company had over $6.6 million in cash and securities, ensuring operational stability through 2025. Despite a slight revenue dip in Q4 2022, NEXGEL launched innovative products like Turfguard and expanded its joint ventures. The gross profit margin improved significantly to approximately 12.5%, a 3,100% increase from the previous year. However, a net loss of $4.75 million was reported for 2022, with expectations of reduced interest expenses in the coming year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Nexgel Wt Exp 120126 (NXGLW)?

The current stock price of Nexgel Wt Exp 120126 (NXGLW) is $0.44 as of May 13, 2025.
Nexgel Inc Wt Exp 120126

Nasdaq:NXGLW

NXGLW Rankings

NXGLW Stock Data

5.59M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE